<DOC>
	<DOCNO>NCT01009333</DOCNO>
	<brief_summary>This study assess effect different InterStim rate setting void diary outcome . Specifically , study evaluate 3 different rate setting affect number urinary incontinent episode per day collect void diary . The study also evaluate 3 different rate setting affect void diary measure include number void per day , degree urgency void , number pad use per day , number fecal incontinent episode , questionnaire , adverse event .</brief_summary>
	<brief_title>InterStim Therapy Programming Study</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence , Urge</mesh_term>
	<criteria>Implanted either Neurostimulator Model 3023 ( InterStim ) Neurostimulator Model 3058 ( InterStim II ) least 3 month Implanted tined lead model 3889 3093 Tined lead locate S2 , S3 , S4 Diagnosis InterStim implant include urgency frequency ( average 8 void per day ) amount urinary urge incontinence void diary reporting period . The diary reporting period must least 2 day . Able tolerate ( ie , complaint pain discomfort ) acute high InterStim rate set Able tolerate ( ie , complaint pain discomfort ) acute medium InterStim rate set Able tolerate ( ie , complaint pain discomfort ) acute low InterStim rate set Must willing maintain current regimen ( dosage frequency ) overactive bladder medication ( anticholinergic antimuscarinic ) tricyclic antidepression medication study duration Female subject 18 year age old Willing able accurately complete void diary questionnaire , attend visit , comply study protocol include maintenance InterStim programming setting course study . Able consent participate signing Informed Consent Form Multiple sclerosis Reiter 's syndrome Exclude diabetic unless subject 's diabetes wellcontrolled diet medication History spinal cord injury cerebral vascular accident ( CVA ) Active symptomatic urinary tract infection ( UTI ) Stress incontinence primary diagnosis Pelvic pain uncertain etiology associate void dysfunction pelvic pain primary complaint/diagnosis Interstitial cystitis primary diagnosis Urinary retention primary diagnosis Treatment urinary symptom botulinum toxin past 12 month plan botulinum toxin treatment study Bilateral lead placement Have implantable neurostimulator , pacemaker , defibrillator Have knowledge plan MRIs , diathermy , microwave exposure , high output ultrasonic exposure , RF energy exposure Have anticipate system modification within next 1 month Women pregnant planning become pregnant woman childbearing potential use medicallyacceptable method birth control . Women childbearing age potential must undergo pregnancy test , clear negative result , 7 day prior randomization visit . Subjects frequently use patient programmer change device program setting . `` Frequently '' define least day include shut device safety purpose . Characteristics indicate poor understanding study characteristic indicate subject may poor compliance study protocol Study site personnel contact Medtronic Study Manager determine potential subject plan enroll another investigational device drug trial , currently enrol investigational device drug trial eligible study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>urgency frequency</keyword>
	<keyword>urinary urge incontinence</keyword>
	<keyword>InterStim Therapy</keyword>
</DOC>